As part of Evaluate’s partnership with Galen Growth, we are delighted to bring you this report on the emergence of artificial intelligence (AI) and the use of Generative AI (GenAI) by Digital Health ventures.
AI in healthcare shows great potential, but it’s important to cut through the hype and understand where the true opportunities lie. Currently, there are over 520 medical devices using AI that have been approved by the FDA, with more on the horizon. Big tech players like Microsoft, Amazon, and Google are investing in AI for Digital Health, but it’s still an emerging technology that requires clinical evidence of success and commercial expertise. Galen Growth has created a report, utilizing data from its HealthTech Alpha solution, to answer big questions and highlight areas of uncertainty.
The report explores how GenAI could drive significant change in healthcare and identifies potential pitfalls.